Peptide therapies are a quickly evolving therapeutic area of medicine with wide-ranging impacts on clinical care and patient health.
Peptides are of particular interest as therapeutic drugs because the body naturally produces many different peptides, this means they are relatively well-tolerated as therapeutics and have fewer side effects.
The majority of naturally occurring peptides bind to cell surface receptors triggering intracellular responses. With over 7,000 peptides that occur naturally in the body, this represents a wide pool of peptides and functions to work with.
Naturally occurring peptides have many different functions from hormones, growth factors, neurotransmitters and more. Therefore, the use of peptides as therapeutics provides a method of targeting a wide range of cells and manipulating their response.
Through cell signaling amino acid sequences, the targeted use of peptides has the potential to rewrite bodily chemistry relationships and build towards regenerative health.
Mission
Through a network of trusted compounding pharmacies, Iron DPC provides patients with access to safe and trusted sources of highest purity peptides that we use on our own parents and ourselves. We source from these pharmacies to find the best rates for members of Iron DPC so they can achieve maximum vitality.
The future of medicine is peptide therapy
Peptide therapies are increasingly playing a significant role in disease state management, performance health, and anti-aging strategies. In clinical practices across the globe, peptide therapies are being used to care for cancer, infectious diseases, metabolic disorders, injuries, aesthetic concerns, and much more. There are many different prospects for the use of peptide therapeutics. The simplest is peptide replacement. Some diseases are due to the body producing a defunct peptide or not producing it at all, for instance, insulin production in diabetes, therefore simply providing the correct functioning peptides may be a sufficient treatment. Peptides have continually demonstrated a real impact on health and wellness, and clinicians, industry players, and patients alike have taken notice. Currently, the global peptide therapeutics market is expected to reach $50.6 billion by the year 2026, at a CAGR of 9.0%. Beyond impressive statistics and proven increases in revenue streams, the use of peptide therapeutics are making long-lasting positive changes in the way clinicians practice medicine and the health outcomes they are able to deliver.
